Migraine Prevention

AHS/AAN Migraine Prevention

AAN GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/61838

Contents of this Issue

Navigation

Page 2 of 7

Treatment Table 1. Classification of Migraine Preventive Therapies (available in the United States) Level A: Established efficacy • Divalproex sodiuma (Depakote® • Sodium valproate • Topiramatea (Topamax® (50–200 mg/d) ) Antidepressants TCA / SSRI / SNRI • Amitriptyline • Venlafaxine Beta-blockers • Metoprolol (200 mg/d) • Timolola (Blocadren® (80 mg/d) ) NSAIDs • Fenoprofen • Ibuprofen • Ketoprofen • Naproxen • Naproxen sodium • Naratriptan (1 mg bid) • Zolmitriptan (2.5 bid/tid) Others Histamines • Histamine subcut ACE inhibitors/ARB • Candesartan • Lisinopril Alpha-agonists • Clonidine • Guanfacine Antihistamines • Cyproheptadine (4 mg/d) Antithrombotics • Acenocoumarol • Coumadin • Picotamide Ca++ Blockers • Nicardipine • Nifedipine • Nimodipine • Verapamil Other • Acetazolamide • Cyclandelate • Hyperbaric oxygen • Flurbiprofen • Mefenamic acid Triptans (For short-term prophylaxis of menstrually related migraine) Frovatriptan • Aspirin • Indomethacin • Propranolola (Inderal® ) • Atenolol • Nadolol • Nebivolol • Pindolol • Bisoprolol • Fluoxetine (20 mg/d) • Fluvoxamine • Protriptyline Level B: Probably effective Antiepileptic drugs (AEDs) ) Level C: Possibly effective • Carbamazepine Level U: Inadequate or conflicting data • Gabapentin (4-week titration phase to 2,400 mg/d)

Articles in this issue

Archives of this issue

view archives of Migraine Prevention - AHS/AAN Migraine Prevention